PAVAN, MATTEO
 Distribuzione geografica
Continente #
AS - Asia 1.098
NA - Nord America 920
EU - Europa 704
AF - Africa 205
SA - Sud America 179
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.128
Nazione #
US - Stati Uniti d'America 824
SG - Singapore 392
CN - Cina 241
IT - Italia 221
HK - Hong Kong 122
BR - Brasile 115
VN - Vietnam 75
DE - Germania 54
FI - Finlandia 48
RU - Federazione Russa 44
NL - Olanda 43
KR - Corea 40
PL - Polonia 40
CI - Costa d'Avorio 30
FR - Francia 27
JP - Giappone 26
ES - Italia 23
GB - Regno Unito 21
AR - Argentina 19
SE - Svezia 17
AT - Austria 15
IN - India 13
AL - Albania 11
ID - Indonesia 11
MX - Messico 11
TN - Tunisia 11
TW - Taiwan 11
ZA - Sudafrica 11
AM - Armenia 10
CA - Canada 10
EC - Ecuador 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
BB - Barbados 9
IR - Iran 9
PT - Portogallo 9
SK - Slovacchia (Repubblica Slovacca) 9
AO - Angola 8
BA - Bosnia-Erzegovina 8
BJ - Benin 8
MT - Malta 8
PK - Pakistan 8
CG - Congo 7
CY - Cipro 7
HT - Haiti 7
HU - Ungheria 7
IE - Irlanda 7
KZ - Kazakistan 7
LA - Repubblica Popolare Democratica del Laos 7
MA - Marocco 7
MK - Macedonia 7
MY - Malesia 7
NP - Nepal 7
PH - Filippine 7
TR - Turchia 7
UA - Ucraina 7
UY - Uruguay 7
VE - Venezuela 7
AU - Australia 6
BO - Bolivia 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
GH - Ghana 6
GN - Guinea 6
GP - Guadalupe 6
IQ - Iraq 6
LC - Santa Lucia 6
NE - Niger 6
NO - Norvegia 6
PS - Palestinian Territory 6
TJ - Tagikistan 6
UG - Uganda 6
BG - Bulgaria 5
BS - Bahamas 5
BZ - Belize 5
CM - Camerun 5
EE - Estonia 5
GA - Gabon 5
GR - Grecia 5
JM - Giamaica 5
JO - Giordania 5
MD - Moldavia 5
MG - Madagascar 5
ML - Mali 5
MU - Mauritius 5
MZ - Mozambico 5
NA - Namibia 5
PY - Paraguay 5
UZ - Uzbekistan 5
AD - Andorra 4
AF - Afghanistan, Repubblica islamica di 4
BE - Belgio 4
BF - Burkina Faso 4
CL - Cile 4
DO - Repubblica Dominicana 4
HN - Honduras 4
HR - Croazia 4
KE - Kenya 4
Totale 2.973
Città #
Singapore 186
Ashburn 157
Hong Kong 114
Santa Clara 83
Beijing 78
Chandler 57
Padova 55
Hefei 49
Los Angeles 32
Abidjan 30
Columbus 30
Bytom 28
Helsinki 28
Seoul 28
Boardman 25
Chicago 24
Ho Chi Minh City 24
Munich 18
Hanoi 17
Fairfield 16
Ogden 16
Houston 14
New York 13
Padua 12
Milan 11
Lappeenranta 10
Baku 9
London 9
Rome 9
San Diego 9
São Paulo 9
Bangkok 8
Barcelona 8
Cotonou 8
Seattle 8
Turku 8
Vienna 8
Warsaw 8
Xewkija 8
Bridgetown 7
Brooklyn 7
Dublin 7
Luanda 7
Montevideo 7
Atlanta 6
Belo Horizonte 6
Brazzaville 6
Buffalo 6
Castries 6
Conakry 6
Council Bluffs 6
Dushanbe 6
Haiphong 6
Kampala 6
Les Abymes 6
Montreal 6
Niamey 6
Paris 6
Stockholm 6
Yerevan 6
Accra 5
Amman 5
Antananarivo 5
Boston 5
Camerino 5
Denver 5
Johannesburg 5
Libreville 5
Maputo 5
Medford 5
Nassau 5
Palermo 5
Prague 5
Princeton 5
Quito 5
Tirana 5
Tokyo 5
Tsukuba 5
Valladolid 5
Vientiane 5
Windhoek 5
Woodbridge 5
Andorra la Vella 4
Athens 4
Bamako 4
Belgrade 4
Cagliari 4
Cambridge 4
Chisinau 4
Cittadella 4
Da Nang 4
Dallas 4
Dar es Salaam 4
Dili 4
Douala 4
Fort Liberté 4
Frankfurt am Main 4
Jakarta 4
Kazan' 4
Panama City 4
Totale 1.577
Nome #
1,2,4-Amino-triazine derivatives as pyruvate dehydrogenase kinase inhibitors: Synthesis and pharmacological evaluation 213
IDENTIFICATION OF NEW SARS-COV-2 MAIN PROTEASE INHIBITORS BY AN INTEGRATED IN-SILICO AND IN-VITRO STRATEGY 172
Tackling the COVID-19 pandemic through the combination of established and novel Computer-Aided Drug Discovery workflows 169
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies 164
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1 delta 146
Qualitative Estimation of Protein-Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations 145
A new inactive conformation of SARS-CoV-2 main protease 144
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma 140
Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations 138
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective? 133
Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease Mpro 130
Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332 130
From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19? 127
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir 122
SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 121
Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study 117
Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism? 112
Computational Strategies to Identify New Drug Candidates against Neuroinflammation 110
Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking {GPCR} Antagonists? 109
Investigating RNA-protein recognition mechanisms through supervised molecular dynamics (SuMD) simulations 108
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)? 106
Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics 105
Thermal Titration Molecular Dynamics (TTMD): Not Your Usual Post-Docking Refinement 99
Streptogramin A derivatives as mitochondrial translation inhibitors to suppress glioblastoma stem cell growth 93
Totale 3.153
Categoria #
all - tutte 11.864
article - articoli 10.926
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/202293 0 0 0 0 3 1 15 11 34 7 7 15
2022/2023197 18 1 2 12 24 17 2 42 30 16 22 11
2023/2024376 15 34 67 26 52 23 39 27 27 20 20 26
2024/2025950 17 74 45 41 121 45 48 91 96 39 133 200
2025/20261.536 222 252 423 373 266 0 0 0 0 0 0 0
Totale 3.153